Skip to main content

Cerebral board ousts CEO Kyle Robertson amid federal probe

Following accusations of overprescribing Adderall and a looming investigation by the Drug Enforcement Agency, the telemedicine firm is changing its leadership.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.